source
- Biogen's tau-targeting Alzheimer's drug shows cognitive slowing in mid-stage trialBiogen reported results from its mid-stage "Celia" trial testing the experimental tau-targeting antibody BIIB080 in patients with early Alzheimer's disease. The study compared three dose levels of…
- Deepfake videos of doctors threaten trust in telehealth and digital careA patient recently presented a video that appeared to show her physician in a white coat, recommending an over‑the‑counter hormone supplement and disparaging standard treatments. The doctor confirm…